HomeCompareVCON vs JNJ

VCON vs JNJ: Dividend Comparison 2026

VCON yields 3.08% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.1K in total portfolio value· pulled ahead in Year 8
10 years
VCON
VCON
● Live price
3.08%
Share price
$65.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.4K
Annual income
$375.14
Full VCON calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — VCON vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCONJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCON + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCON pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCON
Annual income on $10K today (after 15% tax)
$261.54/yr
After 10yr DRIP, annual income (after tax)
$318.87/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,718.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCON + JNJ for your $10,000?

VCON: 50%JNJ: 50%
100% JNJ50/50100% VCON
Portfolio after 10yr
$27.4K
Annual income
$2,562.51/yr
Blended yield
9.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VCON
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCON buys
0
JNJ buys
0
No recent congressional trades found for VCON or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCONJNJ
Forward yield3.08%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$24.4K$30.5K
Annual income after 10y$375.14$4,749.88
Total dividends collected$3.4K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VCON vs JNJ ($10,000, DRIP)

YearVCON PortfolioVCON Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,008$307.69$10,594$274.49+$414.00VCON
2$12,095$316.54$11,294$360.69+$801.00VCON
3$13,266$325.05$12,133$476.91+$1.1KVCON
4$14,528$333.21$13,156$635.42+$1.4KVCON
5$15,886$341.03$14,432$854.61+$1.5KVCON
6$17,347$348.51$16,056$1,162.76+$1.3KVCON
7$18,917$355.66$18,175$1,604.53+$742.00VCON
8← crossover$20,603$362.48$21,009$2,252.68$406.00JNJ
9$22,415$368.97$24,911$3,229.73$2.5KJNJ
10$24,359$375.14$30,458$4,749.88$6.1KJNJ

VCON vs JNJ: Complete Analysis 2026

VCONStock

Vicon Industries, Inc. designs, develops, assembles, and markets video management systems and system components for use in security, surveillance, safety, and communication applications worldwide. Its product line comprises various video and access control system elements, including cameras for image capture and stand-alone network video management system software, as well as various video recording, storage, management, output devices, and door controllers and peripherals; analog, digital, and high definition megapixel cameras for fixed and robotic positioning applications; and other video system components, such as video encoders decoders and monitors, camera lenses, housings and mounts, matrix video switchers and controls, and various video transmission devices. The company's access control system comprises electronic door controllers and communication panels, which is managed by network access control software. Its products are used by commercial and industrial users comprising office buildings, manufacturing plants, warehouses, apartment complexes, shopping malls, and retail stores; federal, state, and local governments for national security purposes, agency facilities, prisons, and military installations; and financial institutions that include banks, clearing houses, brokerage firms, and depositories for security purposes. The company's products are also used by transportation departments for highway traffic control, and bridge and tunnel monitoring, as well as airport, subway, bus, and seaport security and surveillance; gaming casinos; health care facilities, which comprise hospitals; and institutions of education, such as schools and universities, as well as hotels and sports arenas. It sells its products primarily to independent dealers, system integrators, and security products distributors. The company was founded in 1967 and is headquartered in Hauppauge, New York.

Full VCON Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VCON vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCON vs SCHDVCON vs JEPIVCON vs OVCON vs KOVCON vs MAINVCON vs ABBVVCON vs MRKVCON vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.